NSAID Use Profiles Derived from Reimbursement Data in France
- 1 September 2004
- Vol. 59 (5) , 541-546
- https://doi.org/10.2515/therapie:2004092
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Risk factors for adverse events in analgesic drug users: results from the PAIN studyPharmacoepidemiology and Drug Safety, 2003
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID usePAIN®, 2000
- Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areasEuropean Journal of Gastroenterology & Hepatology, 2000
- The PAIN Study: Paracetamol, Aspirin and Ibuprofen New Tolerability StudyClinical Drug Investigation, 1999
- Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort studyBMJ, 1997
- Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysisBMJ, 1996
- Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic researchJournal of Clinical Epidemiology, 1994
- Nonsteroidal Antiinflammatory Drugs and Gastrointestinal Hospitalizations in Saskatchewan: A Cohort StudyEpidemiology, 1992